DB16381InvestigationalProtein Based Therapies
Zampilimab is under investigation in clinical trial NCT04335578 (A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of UCB7858 in Adult Kidney Transplant Recipients With Chronic Allograft Injury).
- Mechanism
- Curator reviewed
Pharmacologically active on Protein-glutamine gamma-glutamyltransferase 2
Resolves to
Compound
Targets
What you can answer from here — as of September 08, 2026
Which drugs share a target with Zampilimab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account